Clinical Trial Innovation Summit 2026

Peer AI at the Clinical Trial Innovation Summit 2026

Peer AI CEO and Co-Founder Anita Modi will speak at the 3rd Annual Clinical Trial Innovation Summit on Tuesday, October 13 at Genentech's campus in South San Francisco, California. CTIS 2026 will explore where innovation is delivering measurable value, where implementation challenges remain, and how successful approaches can be scaled responsibly to improve the patient experience.

Fireside Chat: The Regulatory Pulse in 2026
3:45 PM PDT
Anita Modi, Co-Founder and CEO, Peer AI
Moderated by Anne Madej, Regulatory Science, Genentech

FDA, legal, and industry perspectives on AI governance, digital endpoints, tokenized data, digital biomarkers, and decentralized oversight. Anita brings the perspective of a team building AI for regulatory submissions, where traceability and human review are requirements from the first draft. She will speak to what AI governance looks like in practice when documents need to stand up to regulatory review.

About the Speaker

Anita Modi is CEO and Co-Founder of Peer AI, an AI platform helping life sciences teams produce regulatory and clinical documentation faster and with greater consistency. Her team is comprised of AI engineers and regulatory medical writers and works with emerging biotech through Top 20 pharma. Anita has spent her career building technology for regulated workflows in life sciences. Previously, she served as the Chief Quality Officer at Science 37 and supported product strategy through its $1B+ IPO. She studied at Princeton and Harvard Business School and is based in San Francisco.